Gerold Bepler, M.D., Ph.D.
Gerold Bepler, M.D., Ph.D., a thoracic oncologist, will begin his new position Feb. 1. He will also take on the role of director of the Cancer Institute and principal investigator of the Karmanos National Cancer Institute Comprehensive Cancer Center Support Grant.
“Dr. Bepler is a rare triple-threat oncologist,” said Valerie Parisi, M.D., M.P.H., M.B.A., interim dean of the School of Medicine. “He is a well-funded investigator and an internationally recognized thoracic oncology clinician. His demonstrated leadership skills at Moffit Cancer Center make him an ideal match for both the Wayne State University School of Medicine and the Karmanos Cancer Institute. I am very excited for the opportunity to work closely with him.”
Dr. Bepler most recently was director of the Comprehensive Lung Cancer Research Center, department chair of Thoracic Oncology and program leader of the Lung Cancer Program at the Moffitt CancerCenter in Tampa, Fla. He also served as professor of Medicine and Oncology at the University of South Florida.
“Dr. Bepler comes to us with exceptional experience in oncology, both in the clinical and research settings,” said Alan S. Schwartz, chairman of the Board of Directors of the Karmanos Cancer Institute. “His expertise, leadership and knowledge will help us achieve our mission as one of the top cancer centers in the nation. We are excited to enter this new chapter under his leadership.”
Schwartz added, “We’re also very grateful for the exceptional leadership of Ann G. Schwartz, Ph.D., M.P.H., who has served as interim CEO through this transition period and has helped lead the search for Dr. Bepler.”
Dr. Schwartz will serve in a transitional capacity as interim executive vice president, assisting Dr. Bepler in the management of administrative affairs to ensure a smooth leadership transition.
"We are extremely pleased that Dr. Bepler will be leading the Karmanos Cancer Institute,” said Jay Noren, M.D., president of Wayne State University. “His experience and credentials as a scientist, researcher and clinician are a perfect match for both Karmanos and Wayne State University. I have no doubt that KCI will grow and prosper under his leadership."
Prior to Dr. Bepler’s tenure at the Moffitt Cancer Center, he was director of the Lung Cancer Program at Roswell Park Cancer Institute in Buffalo, NY. Before that, he held positions at Duke University Hospital and Durham VA Medical Center.
As a thoracic oncologist, Dr. Bepler’s research has focused on the treatment of non-small cell lung cancer, the most common form of lung cancer. He has received more than $23.8 million in research funding from the National Cancer Institute over the past 13 years. He has published more than 100 peer-reviewed articles, including articles in the New England Journal of Medicine, the Journal of Clinical Oncology and Cancer Research.
Dr. Bepler has received several awards and recognitions, including the Moffitt Cancer Center’s Scientist of the Year (2008), American College of Physicians Information and Education Resource Editorial Consultant (2007-2008) and served on the Journal of Clinical Oncology Editorial Board (2006-2008). He holds seven patents.
“I’m looking forward to working with the talented and dedicated staff at the Karmanos Cancer Institute, whose work I’ve respected for years,” Dr. Bepler said. “I also look forward to serving in this leadership role, working with partners such as the WSU School of Medicine and the Detroit Medical Center. I feel very privileged to be part of the Karmanos team, with its outstanding reputation, locally, nationally and internationally. Together, we will chart a strong future for the institute.”
Dr. Bepler received his medical and doctorate degrees from the Philipps University School of Medicine and Dentistry in Marburg, Germany. His postdoctoral fellowships were completed at the National Cancer Institute, Philipps University and at Duke University Medical Center.Dr. Bepler is married and has four children.